 |
(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime |
|---|---|
| Trade Name | Gimatecan |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2002-11-29 00:00:00 |
| Sponsor | Sigma-Tau Research, Inc.;9841 Washingtonian Blvd, Suite 502;Gaithersburg, Maryland, 20878 |
Related Access Program